{
  "generated": "2025-11-06T07:16:45.017971+00:00",
  "policy_fingerprint": "0x6036438e1b958d88",
  "source_evidence": "entries/metabolic/nicotinamide-mononucleotide-long-lon02/longevity/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "LONG-LON02_01",
      "year": 2018,
      "design": "randomized controlled trial",
      "journal": "longevity_journal",
      "outcome": "mitochondrial_function",
      "population": "Adults with mitochondrial function concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/nicotinamide-mononucleotide-long-lon02-01",
      "url": "https://doi.org/10.1234/nicotinamide-mononucleotide-long-lon02-01",
      "citation": "LONG-LON02_01 (2018); Journal: longevity_journal; Design: randomized controlled trial; Population: Adults with mitochondrial function concerns; Outcome: mitochondrial_function; DOI: 10.1234/nicotinamide-mononucleotide-long-lon02-01; Adverse Events: None reported."
    },
    {
      "study_id": "LONG-LON02_02",
      "year": 2019,
      "design": "randomized controlled trial",
      "journal": "longevity_journal",
      "outcome": "mitochondrial_function",
      "population": "Adults with mitochondrial function concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/nicotinamide-mononucleotide-long-lon02-02",
      "url": "https://doi.org/10.1234/nicotinamide-mononucleotide-long-lon02-02",
      "citation": "LONG-LON02_02 (2019); Journal: longevity_journal; Design: randomized controlled trial; Population: Adults with mitochondrial function concerns; Outcome: mitochondrial_function; DOI: 10.1234/nicotinamide-mononucleotide-long-lon02-02; Adverse Events: None reported."
    },
    {
      "study_id": "LONG-LON02_03",
      "year": 2020,
      "design": "randomized controlled trial",
      "journal": "longevity_journal",
      "outcome": "mitochondrial_function",
      "population": "Adults with mitochondrial function concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/nicotinamide-mononucleotide-long-lon02-03",
      "url": "https://doi.org/10.1234/nicotinamide-mononucleotide-long-lon02-03",
      "citation": "LONG-LON02_03 (2020); Journal: longevity_journal; Design: randomized controlled trial; Population: Adults with mitochondrial function concerns; Outcome: mitochondrial_function; DOI: 10.1234/nicotinamide-mononucleotide-long-lon02-03; Adverse Events: None reported."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/nicotinamide-mononucleotide-long-lon02-01",
      "study_ids": [
        "LONG-LON02_01"
      ],
      "primary_study_id": "LONG-LON02_01",
      "url": "https://doi.org/10.1234/nicotinamide-mononucleotide-long-lon02-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/nicotinamide-mononucleotide-long-lon02-02",
      "study_ids": [
        "LONG-LON02_02"
      ],
      "primary_study_id": "LONG-LON02_02",
      "url": "https://doi.org/10.1234/nicotinamide-mononucleotide-long-lon02-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/nicotinamide-mononucleotide-long-lon02-03",
      "study_ids": [
        "LONG-LON02_03"
      ],
      "primary_study_id": "LONG-LON02_03",
      "url": "https://doi.org/10.1234/nicotinamide-mononucleotide-long-lon02-03"
    }
  ],
  "manifest_hash": "sha256:f33f2511410650bac3da376a71d3dc7b374eebd7bbb0e7a0b5dcc6707809d44c"
}
